Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC114 Early Access for HIV-1
NCT01702090Phase 4Completed
- Sponsor
- Janssen-Cilag
- Start
- Feb 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen-Cilag. Started Feb 2012; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01702090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702090.